-
Tytuł:
-
First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.
-
Autorzy:
-
Aubry A; UPMC Université, Paris, France; INSERM U1135, Paris, France; Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France.
Sougakoff W; UPMC Université, Paris, France; INSERM U1135, Paris, France; Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France.
Bodzongo P; Faculté des Sciences de la Santé, Brazzaville, Congo.
Delcroix G; Laboratoire de Bactériologie-Hygiène du CHRU, Lille, France.
Armand S; Laboratoire de Bactériologie-Hygiène du CHRU, Lille, France.
Millot G; Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France.
Jarlier V; UPMC Université, Paris, France; INSERM U1135, Paris, France; Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France.
Courcol R; Laboratoire de Bactériologie-Hygiène du CHRU, Lille, France; Université Lille Nord de France, Lille, France; UDSL, F-59000 Lille, France; INSERM U1019-UMR8204, Lille, France.
Lemaître N; Laboratoire de Bactériologie-Hygiène du CHRU, Lille, France; Université Lille Nord de France, Lille, France; UDSL, F-59000 Lille, France; INSERM U1019-UMR8204, Lille, France.
-
Źródło:
-
PloS one [PLoS One] 2014 Apr 17; Vol. 9 (4), pp. e95083. Date of Electronic Publication: 2014 Apr 17 (Print Publication: 2014).
-
Typ publikacji:
-
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: San Francisco, CA : Public Library of Science
-
MeSH Terms:
-
Fluoroquinolones*
Mutation, Missense*
DNA Gyrase/*genetics
Drug Resistance, Bacterial/*genetics
Mycobacterium tuberculosis/*genetics
Amino Acid Substitution ; Congo/epidemiology ; DNA Mutational Analysis ; Female ; Humans ; Male ; Mycobacterium tuberculosis/isolation & purification ; Tuberculosis/epidemiology ; Tuberculosis/genetics
-
References:
-
J Clin Microbiol. 2006 Mar;44(3):688-92. (PMID: 16517840)
BMC Res Notes. 2012 Mar 21;5:160. (PMID: 22436423)
PLoS One. 2011 Apr 20;6(4):e18601. (PMID: 21533101)
J Clin Microbiol. 2001 Aug;39(8):2799-806. (PMID: 11473995)
J Clin Microbiol. 2012 Nov;50(11):3732-4. (PMID: 22895034)
J Clin Microbiol. 1995 Dec;33(12):3234-8. (PMID: 8586708)
J Clin Pathol. 1966 Nov;19(6):583-8. (PMID: 4162852)
BMC Microbiol. 2008 Jun 25;8:103. (PMID: 18578864)
Antimicrob Agents Chemother. 2006 Jan;50(1):104-12. (PMID: 16377674)
J Antimicrob Chemother. 2007 May;59(5):1031-3. (PMID: 17329272)
J Antimicrob Chemother. 2012 Apr;67(4):819-31. (PMID: 22279180)
Antimicrob Agents Chemother. 2009 Oct;53(10):4498-500. (PMID: 19687244)
PLoS One. 2012;7(6):e39754. (PMID: 22761889)
Antimicrob Agents Chemother. 2014;58(1):11-8. (PMID: 24100497)
J Clin Microbiol. 2010 May;48(5):1683-9. (PMID: 20335420)
Am Rev Respir Dis. 1963 May;87:775-9. (PMID: 13927224)
Tuber Lung Dis. 1998;79(1):3-29. (PMID: 10645439)
BMC Infect Dis. 2013 Sep 14;13:432. (PMID: 24034230)
J Clin Microbiol. 2006 Dec;44(12):4498-510. (PMID: 17005759)
J Clin Microbiol. 2010 Nov;48(11):4102-6. (PMID: 20739484)
J Clin Microbiol. 2009 Nov;47(11):3501-6. (PMID: 19759221)
Antimicrob Agents Chemother. 2011 May;55(5):2032-41. (PMID: 21300839)
J Clin Microbiol. 2010 Aug;48(8):2749-53. (PMID: 20554815)
Antimicrob Agents Chemother. 2011 Oct;55(10):4524-9. (PMID: 21768507)
Clin Infect Dis. 1999 Jul;29(1):85-92; discussion 93-5. (PMID: 10433569)
J Clin Microbiol. 2000 Mar;38(3):1094-104. (PMID: 10699003)
JAMA. 2005 Jun 8;293(22):2726-31. (PMID: 15941801)
J Clin Microbiol. 2007 Aug;45(8):2635-40. (PMID: 17537937)
J Clin Microbiol. 2007 Mar;45(3):921-7. (PMID: 17251410)
J Clin Microbiol. 1999 Jan;37(1):45-8. (PMID: 9854062)
-
Substance Nomenclature:
-
0 (Fluoroquinolones)
EC 5.99.1.3 (DNA Gyrase)
-
Entry Date(s):
-
Date Created: 20140419 Date Completed: 20141230 Latest Revision: 20211021
-
Update Code:
-
20240104
-
PubMed Central ID:
-
PMC3990612
-
DOI:
-
10.1371/journal.pone.0095083
-
PMID:
-
24743770
-
Background: Tuberculosis (TB) is one of the major public health problems in Congo. However, data concerning Mycobacterium tuberculosis drug resistance are lacking because of the insufficient processing capacity. So, the aim of this study was to investigate for the first time the resistance patterns and the strain lineages of a sample of M. tuberculosis complex (MTBC) isolates collected in the two main cities of Congo.
Methods: Over a 9-day period, 114 smear-positive sputa isolated from 114 patients attending centers for the diagnosis and treatment of TB in Brazzaville and Pointe Noire were collected for culture and drug susceptibility testing (DST). Detection of mutations conferring drug resistance was performed by using line probe assays (GenoType MTBDRplus and MTBDRsl) and DNA sequencing. Strain lineages were determined by MIRU-VNTR genotyping.
Results: Of the 114 sputa, 46 were culture positive for MTBC. Twenty-one (46%) were resistant to one or more first-line antiTB drugs. Of these, 15 (71%) were multidrug resistant (MDR). The most prevalent mutations involved in rifampin and isoniazid resistance, D516V (60%) in rpoB and S315T (87%) in katG respectively, were well detected by MTBDRplus assay. All the 15 MDR strains were susceptible to fluoroquinolone and injectable second-line drug. No mutation was detected in the rrs locus involved in resistance to amikacin and capreomycin by both the MTBDRsl assay and DNA sequencing. By contrast, 9 MDR strains belonging to the same cluster related to T-family were identified as being falsely resistant to fluoroquinolone by the MTBDRsl assay due to the presence of a double substitution T80A-A90G in GyrA.
Conclusions: Taken together, these data revealed a possible spread of a particular MDR clone in Congo, misidentified as fluoroquinolone resistant by MTBDRsl assay. Thus, this test cannot replace gold-standard culture method and should be interpreted carefully in view of the patient's native land.
Erratum in: PLoS One. 2014;9(11):e113219.
